DRUG ACCESS

India manufactures APIs for over 400 FDA-approved orphan drugs, but patients face high costs due to Indian pharmaceutical companies' reluctance to develop these drugs domestically.

The government has expanded a committee to look into pricing reforms for drugs and medical devices, including civil rights activists like All India Drug Action Network (AIDAN), Patient Safety and Access Initiative of India Foundation, and Medecins S...

Earlier, in January India's Drug Technical Advisory Board (DTAB), India's apex drug advisory body, deliberated on the issue of same brand name (including look-alike and sound-alike ones) for different category of products and it suggested that to en...

In what could ease access to some patented medicines, the government has allowed global tenders to be floated for procurement of 120 drugs, including anti-diabetic medication Semaglutide, after the health ministry raised concerns over lack of domest...

Social Justice and Empowerment Minister Dr Virendra Kumar outlined the 100-day plan, emphasizing initiatives like Accessible India 2.0 and expanding the Nasha Mukt Bharat campaign.

A 2019 study published by the Indian Journal of Gastroenterology revealed that the prevalence of GERD in the Indian population is around 8.2%, with a higher prevalence of around 11.1% in the urban population. According to AWACS MAT April 2024 data, ...

A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis, characterized by delayed stomach emptying. The study, presented at Digestive Disease Week 2024, indicates a 30% higher ris...

A new analysis highlights the significant cardiovascular benefits of Novo Nordisk's obesity drug Wegovy, showing improvements regardless of weight loss amount. This challenges perceptions of GLP-1 drugs, suggesting they could be viewed more as heart...

SII said, in a statement on Friday that the partnership with IntegriMedical aligns with its vision of 'Health for All' and IntegriMedical's mission to 'transform healthcare globally' by providing patient comfort, ensuring increased patient complianc...

India's drug regulator has directed state counterparts to provide a list of antibiotic combinations licensed for manufacturing and marketing within two weeks to combat misuse. This move follows recommendations from an expert sub-committee under the ...

Serum Institute of India acquires 20% stake in IntegriMedical for N-FIS drug delivery solution. Adar Poonawalla envisions a needle-free vaccine administration. N-FIS has regulatory approvals and patented technology. Available in the Indian private m...

Pichai, who is also the chief executive of Alphabet, Google's parent company, was talking a day after announcing several of Google's innovations in his keynote address at Google I/O connect, the company's annual developer conference. "AI tools for a...

Government policy is to provide free diagnosis and treatment to all registered TB cases. Yet patients pay ‘out-of-pocket’ for several other components such as consultation fees, non-TB drugs, other diagnostic tests, travel expenses in pre-treatment ...

Biocon partners with Medix to distribute Liraglutide for chronic weight management in Mexico, offering affordable obesity treatment options. The collaboration aims to improve patient access and quality of life in a country with high obesity rates.

US wellness influencers on platforms like TikTok and Instagram are spreading misinformation about birth control pills, making false claims about infertility and low libido. This misinformation can lead to unintended pregnancies, especially as reprod...

With the latest incarnation of AlphaFold, researchers at DeepMind and sister company Isomorphic Labs - both overseen by cofounder Demis Hassabis - have mapped the behaviour for all of life's molecules, including human DNA.

A government-appointed panel is considering allowing commonly used cough and cold medicines, antacids, and fever-reducing drugs to be sold over the counter (OTC) at general stores in India. While countries like Britain, the US, and Australia have cl...

Implemented on 1 May 2022, the UAE-India CEPA offers numerous trade benefits, including the elimination and reduction of tariffs, an open trade environment, and enhanced market access for service providers across various sectors. It also addresses t...

Zydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market. The company is also preparing to launch the 50 mg tablets in the market. Mirabegron is indicated for the treatment ...